Seoul Pharma Co., Ltd (KOSDAQ:018680)
3,315.00
+5.00 (0.15%)
At close: Aug 22, 2025, 3:30 PM KST
Seoul Pharma Revenue
Seoul Pharma had revenue of 12.89B KRW in the quarter ending March 31, 2025, a decrease of -4.04%. This brings the company's revenue in the last twelve months to 53.04B, down -0.59% year-over-year. In the year 2024, Seoul Pharma had annual revenue of 53.58B with 2.14% growth.
Revenue (ttm)
53.04B
Revenue Growth
-0.59%
P/S Ratio
0.73
Revenue / Employee
303.46M
Employees
172
Market Cap
38.30B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 53.58B | 1.12B | 2.14% |
Dec 31, 2023 | 52.46B | 2.40B | 4.80% |
Dec 31, 2022 | 50.06B | 9.59B | 23.71% |
Dec 31, 2021 | 40.46B | -11.77B | -22.53% |
Dec 31, 2020 | 52.23B | -1.72B | -3.19% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 308.59T |
SK hynix | 77.21T |
LG Energy Solution | 25.16T |
Samsung Biologics | 5,031.69B |
Hyundai Motor Company | 182.25T |
Hanwha Aerospace | 19.25T |
HD Hyundai Heavy Industries | 15.58T |
Doosan Enerbility | 16.30T |